Park Avenue Securities’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $676K | Buy |
2,353
+39
| +2% | +$11.2K | 0.01% | 934 |
|
|
2025
Q1 | $713K | Sell |
2,314
-300
| -11% | -$92.4K | 0.01% | 727 |
|
|
2024
Q4 | $922K | Buy |
2,614
+407
| +18% | +$144K | 0.01% | 807 |
|
|
2024
Q3 | $791K | Buy |
2,207
+170
| +8% | +$60.9K | 0.01% | 780 |
|
|
2024
Q2 | $649K | Buy |
2,037
+475
| +30% | +$151K | 0.01% | 843 |
|
|
2024
Q1 | $359K | Buy |
1,562
+155
| +11% | +$35.6K | ﹤0.01% | 1100 |
|
|
2023
Q4 | $309K | Buy |
1,407
+66
| +5% | +$14.5K | ﹤0.01% | 1116 |
|
|
2023
Q3 | $303K | Buy |
+1,341
| New | +$303K | ﹤0.01% | 1045 |
|
|
2023
Q1 | – | Sell |
-1,116
| Closed | -$310K | – | 1145 |
|
|
2022
Q4 | $310K | Buy |
+1,116
| New | +$310K | 0.01% | 969 |
|